Submitted:
12 January 2026
Posted:
13 January 2026
You are already at the latest version
Abstract
Keywords:
1. Introduction
3. Curently Trends in Monitoring the Life Style in Patient Diagnosed with HIV
2. HIV Management
4. Conclusions
References
- Lifson, AR; Belloso, WH; Carey, C; et al. Determination of the underlying cause of death in three multicenter international HIV clinical trials. HIV Clin Trials. 2008, 9, 177–185. [Google Scholar] [CrossRef]
- Deeks, SG; Phillips, AN. HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity. BMJ. 2009, 338, a3172. [Google Scholar] [CrossRef] [PubMed]
- Baker, J; Ayenew, W; Quick, H; et al. High-density lipoprotein particles and markers of inflammation and thrombotic activity in patients with untreated HIV infection. J Infectious Dis. 2010, 201, 285–292. [Google Scholar] [CrossRef]
- Funderburg, NT; Mayne, E; Sieg, SF; et al. Increased tissue factor expression on circulating monocytes in chronic HIV infection: relationship to in vivo coagulation and immune activation. Blood. 2010, 115, 161–167. [Google Scholar] [CrossRef] [PubMed]
- Neuhaus, J; Jacobs, DR, Jr.; Baker, JV; et al. Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection. J Infect Dis. 2010, 201, 1788–1795. [Google Scholar] [CrossRef]
- Jong, E; Louw, S; Meijers, JC; et al. The hemostatic balance in HIV-infected patients with and without anti-retroviral therapy: partial restoration with antiretroviral therapy. AIDS Patient Care STDS. 2009, 23, 1001–1007. [Google Scholar] [CrossRef] [PubMed]
- Pontrelli, G; Martino, AM; Tchidjou, HK; et al. HIV is associated with thrombophilia and high D-dimer in children and adolescents. AIDS. 2010, 24, 1145–1151. [Google Scholar] [CrossRef]
- Paydas, S.; Ergin, M.; Seydaoglu, G.; Erdogan, S.; Yavuz, S. Pronostic significance of angiogenic/lymphangiogenic, anti-apoptotic, inflammatory and viral factors in 88 cases with diffuse large b cell lymphoma and review of the literature. Leuk. Res. 2009, 33, 1627–1635. [Google Scholar] [CrossRef]
- Bates, D.O. An unexpected tail of vegf and plgf in pre-eclampsia. Biochem. Soc. Trans. 2011, 1576–1582. [Google Scholar] [CrossRef]
- Fagiani, E.; Christofori, G. Angiopoietins in angiogenesis. Cancer Lett. 2013, 328, 18–26. [Google Scholar] [CrossRef]
- Findley, C.M.; Mitchell, R.G.; Duscha, B.D.; Annex, B.H.; Kontos, C.D. Plasma levels of soluble tie2 and vascular endothelial growth factor distinguish critical limb ischemia from intermittent claudication in patients with peripheral arterial disease. J. Am. Coll. Cardiol. 2008, 52, 387–393. [Google Scholar] [CrossRef] [PubMed]
- Engelman, JA; Zejnullahu, K; Mitsudomi, T; Song, Y; Hyland, C; Park, JO.; et al. MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling. Science. 2007, 316, 1039–1043. [Google Scholar] [CrossRef]
- Nahta, R; Yuan, LXH; Zhang, B; Kobayashi, R; Esteva, FJ. Insulin-like growth factor-I receptor/human epidermal growth factor receptor 2 heterodimerization contributes to trastuzumab resistance of breast cancer cells. Cancer Res. 2005, 65, 11118–111128. [Google Scholar] [CrossRef]
- Muñoz, N; Bosch, FX; de Sanjosé, S; Herrero, R; Castellsagué, X; et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003, 348, 518–527. [Google Scholar] [CrossRef]
- Mork, J; Lie, AK; Glattre, E; Hallmans, G; Jellum, E; et al. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med. 2001, 344, 1125–1131. [Google Scholar] [CrossRef] [PubMed]
- Ray, P.; Liu, XH.; Xu, L.; et al. Basic fibroblast growth factor in HIV-associated hemolytic uremic syndrome. Pediatr Nephrol 1999, 13, 586–593. [Google Scholar] [CrossRef] [PubMed]
- Bhattacharya, G. Social capital and HIV risks among acculturating Asian Indian men in New York City. AIDS Educ Prev 2005, 17, 555–567. [Google Scholar] [CrossRef]
- Thompson, MA; Horberg, MA; Agwu, AL; Colasanti, JA; Jain, MK; Short, WR; Singh, T; Aberg, JA. Primary Care Guidance for Persons With Human Immunodeficiency Virus: 2020 Update by the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis. 2021, 73, e3572–e3605. [Google Scholar] [CrossRef]
- Thio, CL; Seaberg, EC; Skolasky, R; Phair, J; Visscher, B; Muñoz, A; Thomas, DL. Multicenter AIDS Cohort Study. HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). Lancet 2002, 360, 1921–1926. [Google Scholar] [CrossRef]
- Yin, Z; Rice, BD; Waight, P; Miller, E; George, R; Brown, AE; Smith, RD; Slack, M; Delpech, VC. Invasive pneumococcal disease among HIV-positive individuals, 2000-2009. AIDS 2012, 26, 87–94. [Google Scholar] [CrossRef]
- van Heuvel, Y; Schatz, S; Rosengarten, JF; Stitz, J. Infectious RNA: Human Immunodeficiency Virus (HIV) Biology, Therapeutic Intervention, and the Quest for a Vaccine. Toxins (Basel) 2022, 14. [Google Scholar] [CrossRef]
- Meissner, ME; Talledge, N; Mansky, LM. Molecular Biology and Diversification of Human Retroviruses. Front Virol. 2022, 2. [Google Scholar] [CrossRef]
- Centers for Disease Control and Prevention (CDC). Revised surveillance case definition for HIV infection--United States, 2014. MMWR Recomm Rep. 2014, 63, 1–10. [Google Scholar]
- Moss Joseph Anthony, HIV/AIDS Review. Radiol Technol. 2013, 84 quiz, 247–267 268-70.
- Raphael, Landovitz J.; Scott, Scott Hyman; Steven, Deeks G. Prevention, treatment and cure of HIV infection. Nat Rev Microbiol. 2023, 21, 657–670. [Google Scholar]
- Steven, Deeks G.; Julie, Overbaugh; Andrew, Phillips; Susan, Buchbinder. HIV infection. Nat Rev Dis Primers 2015, 1, 15035. [Google Scholar]
- UN Joint Programme on HIV/AIDS (UNAIDS). AIDS, crisis and the power to transform: UNAIDS Global AIDS Update 2025. 2025; 1–116. [Google Scholar]
- Goosby, E; Dybul, M; Fauci, AS; Fu, J; Walsh, T; Needle, R; et al. The United States President’s Emergency Plan for AIDS Relief: a story of partnerships and smart investments to turn the tide of the global AIDS pandemic. J Acquir Immune Defic Syndr. 2012, 60, S51–S56. [Google Scholar] [CrossRef] [PubMed]
- Fauci, AS; Folkers, GK; Lane, H. Human immunodeficiency virus disease: AIDS and related disorders. In Harrison’s principles of internal medicine, 22nd ed.; Longo, D, Fauci, A, Kasper, D, Hauser, S, Jameson, J, Loscalzo, J, et al., Eds.; McGraw Hill, 2026. [Google Scholar]
- Bekker, L-G; Das, M; Abdool Karim, Q; Ahmed, K; Batting, J; Brumskine, W; et al. Twice-yearly lenacapavir or daily F/TAF for HIV prevention in cisgender women. N Engl J Med. 2024, 391, 1179–1192. [Google Scholar] [CrossRef] [PubMed]
- Thompson, MA; Horberg, MA; Agwu, AL; Colasanti, JA; Jain, MK; Short, WR; Singh, T; Aberg, JA. Primary Care Guidance for Persons With Human Immunodeficiency Virus: 2020 Update by the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis. 2021, 73, e3572–e3605. [Google Scholar] [CrossRef]
- Thio, CL; Seaberg, EC; Skolasky, R; Phair, J; Visscher, B; Muñoz, A; Thomas, DL. Multicenter AIDS Cohort Study. HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). Lancet 2002, 360, 1921–1926. [Google Scholar] [CrossRef] [PubMed]
- Yin, Z; Rice, BD; Waight, P; Miller, E; George, R; Brown, AE; Smith, RD; Slack, M; Delpech, VC. Invasive pneumococcal disease among HIV-positive individuals, 2000-2009. AIDS 2012, 26, 87–94. [Google Scholar] [CrossRef] [PubMed]
- Gandhi, RT; Bedimo, R; Hoy, JF; Landovitz, RJ; Smith, DM; Eaton, EF; Lehmann, C; Springer, SA; Sax, PE; Thompson, MA; Benson, CA; Buchbinder, SP; Del Rio, C; Eron, JJ; Günthard, HF; Molina, JM; Jacobsen, DM; Saag, MS. Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2022 Recommendations of the International Antiviral Society-USA Panel. JAM 2023, 329, 63–84. [Google Scholar] [CrossRef] [PubMed]
- Jacobson, K; Ogbuagu, O. Integrase inhibitor-based regimens result in more rapid virologic suppression rates among treatment-naïve human immunodeficiency virus-infected patients compared to non-nucleoside and protease inhibitor-based regimens in a real-world clinical setting: A retrospective cohort study. Medicine (Baltimore) 2018, 97, e13016. [Google Scholar] [PubMed]



Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
